
We are pleased to announce that our Head of ECM, Jakob Schmidt, has been named Partner at Translution Capital
Jakob Schmidt has been instrumental in building our rapidly expanding ECM practice, a business we expect will continue to grow in the coming years
Please join us in congratulating Jakob.
ABOUT TRANSLUTION CAPITAL
Translution Capital is a Nordic Corporate Finance house devising and executing innovative and customized solutions to our clients’ most challenging issues
Our operation is independent and free of any potential conflict of interest inherent within large multi-product financial institutions.
Translution Capital strongly believe in best-in-class execution as trusted Corporate Finance advisor within M&A, ECM and DCM regardless of sector, size and situation
We operate from a platform with strong and proven reach to domestic, Nordic and international Institutional and HNI investors
ABOUT JAKOB SCHMIDT
Jakob Schmidt started his career in investment banking and eventually became Head of ECM at Carnegie Denmark. Most recently he was CEO in Exruptive. Prior to that he was SVP at Falck and before that CEO in Pharmexa. Jakob Schmidt sits on the board of the LINX Association, a non-profit partnership linking industry and universities around materials research. Other previous positions include Chairman of the Board of Directors in Gudme Raaschou Vision, Chairman of the Board of Directors in Curalogic as well as Chairman of the Board of Directors in GemVax AS and Pharmexa Inc.